Watanabe Todd Franklin

Watanabe Todd Franklin is listed in filings as See Remarks at Arcutis Biotherapeutics, Inc. - Common stock. This profile follows SEC Form 4 activity through Jun 12, 2025, including sale activity and purchase activity. Recent filings connect the profile to Arcutis Biotherapeutics, Inc. - Common stock (ARQT). The current snapshot covers public activity from Aug 5, 2024 to Jun 12, 2025. Reported amounts are shown as $173.9K to $26.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.